Findings reported by Micevic et al. [15] suggest that the hypomethylation of PD-L1 (and possible subsequent increased protein expression of PD-L1) is associated with a phenotype of immune activation and expression of interferon signaling pathway genes in cutaneous melanoma. This evidence concerns the gene CD274 and cutaneous melanoma.